Biocon Q3 Results Review - Aggressive Capital Allocation Led To Suppressed Return Ratios: Axis Securities

The capital allocation on two fronts R&D, acqustion of Viatris has diluted return ratios to below ~10% despite growth in business.

<div class="paragraphs"><p>Biocon Research Centre in Bengaluru. (Photo: company website)</p></div>
Biocon Research Centre in Bengaluru. (Photo: company website)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More